Patented Medicine Prices Review Board: PMPRB report reviews new drugs and their potential impact on future drug spending in Canada
Patented Medicine Prices Review BoardCanada News Centre |
PMPRB report reviews new drugs and their potential impact on future drug spending in Canada by Patented Medicine Prices Review Board Canada on Tuesday 05 November 2024 08:00 PM UTC+00 | Tags: news-releases The latest edition of Meds Pipeline Monitor provides stakeholders with a list of new medicines in the late stages of clinical evaluation that may significantly impact clinical practice or drug spending in the coming years. Tags:
|
0 comments